Video

What is the evidence that personalized, gene-directed therapy, in which molecular drivers identified by NGS produce treatments that are better aligned with actionable targets, will improve outcomes?

Name: What is the evidence that personalized, gene-directed therapy, in which molecular drivers identified by NGS produce treatments that are better aligned with actionable targets, will improve outcomes?
Uploaded: 2017-09-25T00:00:00+00:00
Description: What is the evidence that more personalized, gene-directed cancer therapy, in which specific molecular drivers identified by NGS will produce treatments that are better aligned with actionable targets and will improve patient outcomes?

Published: September 25, 2017

What is the evidence that personalized, gene-directed therapy, in which molecular drivers identified by NGS produce treatments that are better aligned with actionable targets, will improve outcomes?

What is the evidence that more personalized, gene-directed cancer therapy, in which specific molecular drivers identified by NGS will produce treatments that are better aligned with actionable targets and will improve patient outcomes?

Overview

CLICK HERE FOR CME CREDIT

Created by

Presenter

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea